WEEK 3
PLEASE SEE ATTACHED
Uncategorized
Major Depression
Diagnosis: Major Depression Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating Major Depression Disorder in children and adolescents. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label
Evidenced-Based Practice Change Presentation
USE THE POWERPOINT TEMPLATE ATTACHED Include the following sections (detailed criteria listed below). Title Slide Introduction (1-2 slides) Identify and describe the patient-focused practice issue. Explain the significance of the issue and its impact on patient health outcomes, nursing practice, or healthcare delivery. You may use the description of the issue completed in Week
Evidenced-Based Practice Change Presentation Read More »
Health Assessment – Topic 5 DQ 2
End-of-life care becomes an issue at some point for elderly patients. Discuss the difference between palliative care and hospice care programs. Discuss what you can do as a nurse to support your patients regarding end-of-life care in accordance with their wishes. Explain the use of advance directives versus Physician Order for Life Sustaining Treatment (POLST)
Health Assessment – Topic 5 DQ 2 Read More »